Abstract
In a previous paper we studied the time evolution of the Covid-19 pandemic in Italy during the first wave of 2020 using a number of distribution laws. We concluded that the best distribution law to predict the evolution of the pandemic, if basic conditions of the pandemic (such as distancing measures, use of masks, start of schools, intensive use of public transportation, beginning and end of holidays, vaccination campaign and no significant onset of new Covid variants) do not appreciably change, is a distribution of the type of Planck’s law with three parameters. In our 2020 study we did not use the number of daily positive cases in Italy but the ratio of daily positive cases per number of daily tests, ratio today sometimes referred to as: “positivity rate”. We showed that, if basic conditions do not change, the Planck’s distribution with three parameters provides very good predictions of the positivity rate about one month in advance. In particular, in a second paper, using the Planck’s distribution with three parameters, we predicted, about one month in advance, the spread of the pandemic in Italy during the Christmas 2020 holidays with an error of a few percent only. We then study the present (September 2021) evolution of the pandemic in Italy and we show that the Planck’s distribution, based on the data of July and August, predicts well the evolution of the pandemic. In particular, we show that the peak of the positivity rate was predicted to occur approximately around the middle of August and that the agreement of this Planck’s function (obtained fitting the data up to 10 July 2021) and the positivity rate observed after 5 weeks, on 12 September 2021 is very good. However, the end of the Italian holidays and the start of all the activities including schools, intensive use of public transportation and further changes in distancing measures may cause a discrepancy of the predicted trend of the positivity rate of the pandemic with respect to the real observed values.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external fundings was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The paper uses public statistics data. IRB and/or ethics committee approvals is not needed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data of the Covid-19 pandemic were obtained from: https://github.com/pcm-dpc/COVID-19/blob/master/dati-andamento-nazionale/dpc-covid19-ita-andamento-nazionale.csv
